ChemicalBook > CAS DataBase List > (3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide

Product Name
(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide
CAS No.
1353644-70-8
Chemical Name
(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide
Synonyms
HMPL309;HMPL 309;HMPL-309;EOS-61583;Theliatinib;Theliatinib (HMPL-309);ThTheliatinib (HMPL-309);HMPL-309;HMPL 309;HMPL309;(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide;Pyrrolo[3,4-b]pyrrole-5(1H)-carboxamide, N-[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]hexahydro-1-methyl-, (3aR,6aR)-
CBNumber
CB23142246
Molecular Formula
C25H26N6O2
Formula Weight
442.51
MOL File
1353644-70-8.mol
More
Less

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide Property

Boiling point:
675.6±55.0 °C(Predicted)
Density 
1.35±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO: 5 mg/mL (11.30 mM)
pka
13.59±0.20(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0027986
Product name
Theliatinib
Purity
99.88%
Packaging
5mg
Price
$240
Updated
2021/12/16
ChemScene
Product number
CS-0027986
Product name
Theliatinib
Purity
99.88%
Packaging
10mg
Price
$390
Updated
2021/12/16
ChemScene
Product number
CS-0027986
Product name
Theliatinib
Purity
99.88%
Packaging
25mg
Price
$780
Updated
2021/12/16
ChemScene
Product number
CS-0027986
Product name
Theliatinib
Purity
99.88%
Packaging
50mg
Price
$1300
Updated
2021/12/16
ChemScene
Product number
CS-0027986
Product name
Theliatinib
Purity
99.88%
Packaging
100mg
Price
$2200
Updated
2021/12/16
More
Less

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide Chemical Properties,Usage,Production

Biological Activity

Theliatinib (HMPL-309) is a potent EGFR inhibitor with a Ki value of 0.05 nM for EGFR and IC50 values of 3 nM and 22 nM for EGFR and EGFR T790M/L858R mutant, respectively. It is more than 50-fold selective for EGFR over 72 other kinases.

in vitro

Compared with erlotinib or gefitnib, theliatinib has stronger binding affinity to wild-type EGFR and is more difficult to be replaced by ATP, which makes theliatinib have better target binding effect, and the EGFR-activated tumors have stronger antitumor activity.

in vivo

Theliatinib has concentration-dependent antitumor activity in a series of patient-derived esophageal cancer xenograft models. But aberrant activation or genetic mutation of other targets such as PI3K and FGFR attenuates the antitumor activity of EGFR inhibitors, especially theliatinib.

target

< td style="border-bottom: 1px dotted #ccc;padding: 5px;"> 3 nM
TargetValue
WT EGFR
(Cell-free assay)
EGFR T790M/L858R
(Cell-free assay)		 22 nM

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide Suppliers

China 35 United States 4 Global 39
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
5281
Advantage
58
Sichuan Wei Keqi Biological Technology Co., Ltd.
Tel
028-81700200 18116577057
Fax
028-81705658
Email
3003855609@qq.com
Country
China
ProdList
7892
Advantage
56
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696，15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4182
Advantage
55
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Country
United States
ProdList
9926
Advantage
65
ShangHai Biochempartner Co.,Ltd
Tel
17754423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8011
Advantage
62
Shanghai Rechem science Co., Ltd.
Tel
21-31433387 15618786686
Fax
QQ:1369748377
Email
sales@rechemscience.com
Country
China
ProdList
2989
Advantage
58
Jinan elephant international trading co., LTD
Tel
Fax
-
Email
13006575422@163.com
Country
China
ProdList
6357
Advantage
58
Kaixin Chemical (Hong Kong) Limited
Tel
010-88886666-01 13112345678
Fax
CDXH21@126.com
Email
loyson@tcypharm.com
Country
China
ProdList
595
Advantage
55
Fan De(Beijing) Biotechnology Co., Ltd.
Tel
15911056312
Email
liming@bio-fount.com
Country
China
ProdList
9730
Advantage
58
Shanghai zhigan biotechnology co., LTD
Tel
Email
zhiqianbio@126.com
Country
China
ProdList
19785
Advantage
58

1353644-70-8, (3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamideRelated Search:

TG4-155 PH 797804 NVP-TAE684 Axitinib Lapatinib Dasatinib Erlotinib Sunitinib Ruxolitinib AZD-9291

  • EOS-61583
  • Theliatinib (HMPL-309)
  • (3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide
  • ThTheliatinib (HMPL-309)
  • Theliatinib
  • HMPL 309
  • HMPL309
  • HMPL-309
  • HMPL-309;HMPL 309;HMPL309
  • ATP-competitive,inhibit,EGFR,ERK,cancer,esophageal,Epidermal growth factor receptor,HMPL-309,anti-tumor,Inhibitor,ErbB-1,HMPL309,Theliatinib,HER1,HMPL 309,orally,Xiliertinib,AKT,phosphorylation
  • Pyrrolo[3,4-b]pyrrole-5(1H)-carboxamide, N-[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]hexahydro-1-methyl-, (3aR,6aR)-
  • 1353644-70-8